TRDA · ISSUER CIK 1689375
Entrada Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 8 Entrada Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $10.3M of sales on SEC Form 4.
↗8 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 12 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$10.3MInsider selling
−$10.3MNet open-market
Sep 9, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 202619:24 | Sep 9, 2026from Sep 4, 2026 | TRDA | 10% Owner · +2 joint | S · Sell | $7.33 | −259,837 | 3,885,115 | -6% | −$1.9M | ||
| Sep 9, 202619:23 | Sep 9, 2026from Sep 4, 2026 | TRDA | 10% Owner · +9 joint | S · Sell | $7.33 | −259,837 | 3,885,115 | -6% | −$1.9M | ||
| Sep 3, 202619:21 | Sep 3, 2026from Sep 1, 2026 | TRDA | 10% Owner · +2 joint | S · Sell | $7.14 | −86,482 | 4,144,952 | -2% | −$617K | ||
| Sep 3, 202619:21 | Sep 3, 2026from Sep 1, 2026 | TRDA | 10% Owner · +9 joint | S · Sell | $7.14 | −86,482 | 4,144,952 | -2% | −$617K | ||
| Sep 3, 202617:19 | Sep 2, 2026 | TRDA | CEO, Director | F · Tax | $7.14 | −8,724 | 517,290 | -2% | $62K | ||
| Sep 3, 202617:18 | Sep 2, 2026 | TRDA | President & COO | F · Tax | $7.14 | −2,528 | 196,060 | -1% | $18K | ||
| Sep 3, 202617:16 | Sep 2, 2026 | TRDA | President, Research & Develop. | F · Tax | $7.14 | −2,079 | 214,238 | -1% | $15K | ||
| Sep 3, 202617:15 | Sep 2, 2026 | TRDA | Chief Financial Officer | F · Tax | $7.14 | −1,733 | 117,277 | -1% | $12K | ||
| Aug 31, 202618:26 | Aug 31, 2026from Aug 27, 2026 | TRDA | 10% Owner · +2 joint | S · Sell | $7.08 | −86,914 | 4,231,434 | -2% | −$616K | ||
| Aug 31, 202618:25 | Aug 31, 2026from Aug 27, 2026 | TRDA | 10% Owner · +9 joint | S · Sell | $7.08 | −86,914 | 4,231,434 | -2% | −$616K | ||
| Aug 26, 202621:28 | Aug 26, 2026from Aug 24, 2026 | TRDA | 10% Owner · +9 joint | S · Sell | $7.36 | −62,714 | 4,318,348 | -1% | −$462K | ||
| Aug 26, 202621:27 | Aug 26, 2026from Aug 24, 2026 | TRDA | 10% Owner · +2 joint | S · Sell | $7.36 | −62,714 | 4,318,348 | -1% | −$462K | ||
| Aug 10, 202619:54 | Aug 10, 2026from Aug 6, 2026 | TRDA | Director | S · Sell | $6.95 | −155,255 | 2,691,337 | -5% | −$1.1M | ||
| Aug 10, 202619:52 | Aug 7, 2026from Aug 6, 2026 | TRDA | 10% Owner · +5 joint | S · Sell | $6.88 | −62,811 | 2,783,781 | -2% | −$432K | ||
| Aug 3, 202617:32 | Jul 31, 2026from Jul 30, 2026 | TRDA | 10% Owner · +5 joint | S · Sell | $6.93 | −116,474 | 2,846,592 | -4% | −$807K | ||
| Aug 3, 202617:26 | Jul 31, 2026from Jul 30, 2026 | TRDA | Director, 10% Owner | S · Sell | $6.93 | −116,474 | 2,846,592 | -4% | −$807K |